Levodopa induces dyskinesias in normal squirrel monkeys
β Scribed by Daniel M. Togasaki; Louis Tan; Peter Protell; Donato A. Di Monte; Maryka Quik; J. William Langston
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 823 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0364-5134
- DOI
- 10.1002/ana.1099
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The antidyskinetic potential of the glutamate NMDA receptor channel blocker amantadine was evaluated in four levodopa-primed parkinsonian monkeys using two different regimens (1.25 or 2.5 mg/kg administered subcutaneously twice daily for 3-6 days). When administered with a relatively low dose of lev
## Abstract It has become increasingly apparent that Parkinson's disease involves many transmitter systems other than dopamine. This nondopaminergic involvement impacts on the generation of symptoms, on the neurodegenerative process, but, most tellingly, in the generation of side effects of current
## Abstract Levodopaβinduced dyskinesias (LIDs) are frequent in parkinsonian patients and may result from an aberrant plasticity. Brainβderived neurotrophic factor (BDNF) represents a likely candidate to subserve neuroadaptive processes encountered in LIDs. We compared striatal BDNF levels measured